Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.

Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G.

Cancer Cell. 2012 Jul 10;22(1):21-35. doi: 10.1016/j.ccr.2012.05.037.

2.
3.

Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.

Nana AW, Yang PM, Lin HY.

Asian Pac J Cancer Prev. 2015;16(16):6813-23. Review.

4.

Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.

Chinot OL.

Expert Rev Anticancer Ther. 2012 Nov;12(11):1413-27. doi: 10.1586/era.12.128. Review.

PMID:
23249106
5.

[Monoclonal antibodies in high-grade gliomas].

Chekhonin IV, Leopold AV, Gurina OI, Semenova AV.

Vestn Ross Akad Med Nauk. 2014;(9-10):131-9. Review. Russian.

PMID:
25816654
6.

Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.

Wang Z, Zhang S, Siu TL, Huang S.

Curr Pharm Des. 2015;21(10):1268-71. Review.

7.

[Anti-angiogenic strategies in glioblastoma].

Guillamo JS.

Rev Neurol (Paris). 2011 Oct;167(10):662-7. doi: 10.1016/j.neurol.2011.07.008. Epub 2011 Sep 1. Review. French.

PMID:
21889779
8.

Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.

De Bonis P, Marziali G, Vigo V, Peraio S, Pompucci A, Anile C, Mangiola A.

Expert Rev Neurother. 2013 Nov;13(11):1263-70. doi: 10.1586/14737175.2013.856264. Review.

PMID:
24175724
9.

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.

Lee JK, Joo KM, Lee J, Yoon Y, Nam DH.

Onco Targets Ther. 2014 Oct 20;7:1933-44. doi: 10.2147/OTT.S36582. eCollection 2014. Review.

10.

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma.

Cruickshanks N, Zhang Y, Yuan F, Pahuski M, Gibert M, Abounader R.

Cancers (Basel). 2017 Jul 11;9(7). pii: E87. doi: 10.3390/cancers9070087. Review.

Supplemental Content

Support Center